These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35634433)

  • 21. Therapeutic Path to Double Knockout: Investigating the Selective Dual-Inhibitory Mechanisms of Adenosine Receptors A1 and A2 by a Novel Methoxy-Substituted Benzofuran Derivative in the Treatment of Parkinson's Disease.
    Subair TI; Soremekun OS; Olotu FA; Soliman MES
    Cell Biochem Biophys; 2021 Mar; 79(1):25-36. PubMed ID: 33222095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of novel pyridazinone-based adenosine receptor ligands.
    Catarzi D; Varano F; Falsini M; Varani K; Vincenzi F; Pasquini S; Dal Ben D; Colotta V
    Bioorg Med Chem Lett; 2018 May; 28(9):1484-1489. PubMed ID: 29627261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
    Yuzlenko O; Kieć-Kononowicz K
    J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A
    Falsini M; Catarzi D; Varano F; Dal Ben D; Marucci G; Buccioni M; Volpini R; Di Cesare Mannelli L; Ghelardini C; Colotta V
    Bioorg Chem; 2019 Jun; 87():380-394. PubMed ID: 30913470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and Structure Activity Relationships of Chalcone based Benzocycloalkanone Derivatives as Adenosine A1 and/or A2A Receptor Antagonists.
    Janse van Rensburg HD; Legoabe LJ; Terre'Blanche G
    Drug Res (Stuttg); 2020 Jun; 70(6):243-256. PubMed ID: 32349128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substituted 4-phenylthiazoles: Development of potent and selective A
    Abdelrahman A; Yerande SG; Namasivayam V; Klapschinski TA; Alnouri MW; El-Tayeb A; Müller CE
    Eur J Med Chem; 2020 Jan; 186():111879. PubMed ID: 31780082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, biological activity and molecular modelling studies of tricyclic alkylimidazo-, pyrimido- and diazepinopurinediones.
    Drabczyńska A; Karcz T; Szymańska E; Köse M; Müller CE; Paskaleva M; Karolak-Wojciechowska J; Handzlik J; Yuzlenko O; Kieć-Kononowicz K
    Purinergic Signal; 2013 Sep; 9(3):395-414. PubMed ID: 23543220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of methoxy substituted 2-benzoyl-1-benzofuran derivatives as lead compounds for the development adenosine A
    Janse van Rensburg HD; Legoabe LJ; Terre'Blanche G; Aucamp J
    Bioorg Chem; 2020 Jan; 94():103459. PubMed ID: 31818481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives with High Affinity for Both the Adenosine A
    Varano F; Catarzi D; Vigiani E; Dal Ben D; Buccioni M; Marucci G; Di Cesare Mannelli L; Lucarini E; Ghelardini C; Volpini R; Colotta V
    Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imidazo[1,2-α]pyridines possess adenosine A
    Lefin R; van der Walt MM; Milne PJ; Terre'Blanche G
    Bioorg Med Chem Lett; 2017 Sep; 27(17):3963-3967. PubMed ID: 28789895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor model.
    Tuccinardi T; Schenone S; Bondavalli F; Brullo C; Bruno O; Mosti L; Zizzari AT; Tintori C; Manetti F; Ciampi O; Trincavelli ML; Martini C; Martinelli A; Botta M
    ChemMedChem; 2008 Jun; 3(6):898-913. PubMed ID: 18338422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors.
    Squarcialupi L; Falsini M; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Dal Ben D; Lambertucci C; Volpini R; Colotta V
    Bioorg Med Chem; 2016 Jun; 24(12):2794-808. PubMed ID: 27161878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and structure-activity relationships of 2-hydrazinyladenosine derivatives as A(2A) adenosine receptor ligands.
    El-Tayeb A; Gollos S
    Bioorg Med Chem; 2013 Jan; 21(2):436-47. PubMed ID: 23245803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-Phenylimidazo[2,1-i]purin-5-ones: structure-activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptors.
    Ozola V; Thorand M; Diekmann M; Qurishi R; Schumacher B; Jacobson KA; Müller CE
    Bioorg Med Chem; 2003 Feb; 11(3):347-56. PubMed ID: 12517430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives.
    Matos MJ; Gaspar A; Kachler S; Klotz KN; Borges F; Santana L; Uriarte E
    J Pharm Pharmacol; 2013 Jan; 65(1):30-4. PubMed ID: 23215685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Derivatives of 4-amino-6-hydroxy-2-mercaptopyrimidine as novel, potent, and selective A3 adenosine receptor antagonists.
    Cosimelli B; Greco G; Ehlardo M; Novellino E; Da Settimo F; Taliani S; La Motta C; Bellandi M; Tuccinardi T; Martinelli A; Ciampi O; Trincavelli ML; Martini C
    J Med Chem; 2008 Mar; 51(6):1764-70. PubMed ID: 18269230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New C2- and N3-Modified Thieno[2,3-d]Pyrimidine Conjugates with Cytotoxicity in the Nanomolar Range.
    Mavrova AT; Dimov S; Yancheva D; Rangelov M; Wesselinova D; Naydenova E
    Anticancer Agents Med Chem; 2022; 22(6):1201-1212. PubMed ID: 34315388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.
    Cappellacci L; Franchetti P; Vita P; Petrelli R; Lavecchia A; Costa B; Spinetti F; Martini C; Klotz KN; Grifantini M
    Bioorg Med Chem; 2008 Jan; 16(1):336-53. PubMed ID: 17933541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: structural investigations at the 5-position to target human A₁ and A(2A) adenosine receptors. Molecular modeling and pharmacological studies.
    Squarcialupi L; Colotta V; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Borea PA; Porta N; Ciancetta A; Moro S
    Eur J Med Chem; 2014 Sep; 84():614-27. PubMed ID: 25063944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of novel thieno[2,3-d]pyrimidine, thieno[2,3-b]pyridine and thiazolo[3,2-a]thieno[2,3-d]pyrimidine derivatives and their effect on the production of mycotoxins.
    Abdelrazek FM; Salah AM; Elbazza ZE
    Arch Pharm (Weinheim); 1992 May; 325(5):301-5. PubMed ID: 1524469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.